Cargando…
microRNAs and prostate cancer
Prostate cancer (CaP) is the most frequently diagnosed malignant tumour and the second leading cause of cancer deaths in American men. One of the most troubling aspects of this disease is that, after androgen ablation therapy, androgen-dependent cancer cells inevitably progress to an androgen-indepe...
Autores principales: | Shi, Xu-Bao, Tepper, Clifford G, White, Ralph W deVere |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918061/ https://www.ncbi.nlm.nih.gov/pubmed/18624768 http://dx.doi.org/10.1111/j.1582-4934.2008.00420.x |
Ejemplares similares
-
MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth
por: Nadiminty, Nagalakshmi, et al.
Publicado: (2012) -
Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer
por: Amir, Sumaira, et al.
Publicado: (2013) -
MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012) -
Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010) -
Targeting MicroRNAs in Prostate Cancer Radiotherapy
por: Ni, Jie, et al.
Publicado: (2017)